Collin Liu, MD
Behavioral Neurology & Nuclear Medicine
Professional Overview
Dr. Collin Liu is a board-certified neurologist with dual specialty training in Behavioral Neurology and Nuclear Medicine. His unique combination of expertise allows him to provide comprehensive care for patients with complex neurological conditions, particularly those affecting cognition and behavior. Dr. Liu's approach integrates advanced neuroimaging techniques with clinical assessment to deliver precise diagnoses and personalized treatment plans.
Patient Care Philosophy
Dr. Liu believes in a patient-centered approach that emphasizes compassionate care, clear communication, and collaborative decision-making. He understands that neurological conditions can be overwhelming for patients and families, and he is committed to providing not only expert medical care but also emotional support and education throughout the treatment journey. His philosophy centers on treating the whole person, not just the condition.
Telehealth Innovation
As a pioneer in neurological telehealth, Dr. Liu has developed innovative protocols for remote cognitive assessments and virtual consultations. His work has made specialized neurological care more accessible to patients in underserved areas. He has published extensively on the effectiveness of telemedicine in neurology and has trained other physicians in best practices for virtual neurological care, particularly during the COVID-19 pandemic.
Academic Leadership
Dr. Liu serves as an Associate Professor of Neurology and is actively involved in medical education. He mentors neurology residents and fellows, teaching advanced neuroimaging interpretation and behavioral neurology assessment techniques. He has received multiple teaching awards and is known for his ability to make complex neurological concepts accessible to learners at all levels. He also serves on several institutional committees focused on improving patient care quality and safety.
Research Excellence
Dr. Liu's research focuses on the intersection of neuroimaging and cognitive disorders, with particular emphasis on early detection of dementia and the development of novel biomarkers for neurodegenerative diseases. He has published numerous peer-reviewed articles in leading neurology journals and has been the Principle Investigator for Alzheimer's disease clinical trials (e.g. amyloid-targeting therapy), and NIH grants. His work has contributed significantly to our understanding of how brain imaging can improve diagnostic accuracy in behavioral neurology.
Education
Board Certifications
• American Board of Nuclear Medicine
Professional Membership
• Society of Nuclear Medicine and Molecular Imaging (SNMMI)